Xencor Inc. diskutieren
Xencor Inc.
WKN: A1W96L / Symbol: XNCR / Name: Xencor / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
14,40 €
1,41 %
Xencor, Inc. (NASDAQ: XNCR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $38.00 price target on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor, Inc. (NASDAQ: XNCR) had its price target raised by analysts at JPMorgan Chase & Co. from $27.00 to $28.00. They now have an "overweight" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor, Inc. (NASDAQ: XNCR) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $34.00 price target on the stock, up previously from $32.00.
Ratings data for XNCR provided by MarketBeat
Xencor, Inc. (NASDAQ: XNCR) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $30.00 price target on the stock, up previously from $20.00.
Ratings data for XNCR provided by MarketBeat
Xencor, Inc. (NASDAQ: XNCR) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $37.00 price target on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor, Inc. (NASDAQ: XNCR) had its price target lowered by analysts at Wells Fargo & Company from $37.00 to $33.00. They now have an "overweight" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor, Inc. (NASDAQ: XNCR) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor, Inc. (NASDAQ: XNCR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $31.00 price target on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor, Inc. (NASDAQ: XNCR) had its price target lowered by analysts at Barclays PLC from $22.00 to $6.00. They now have an "underweight" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor, Inc. (NASDAQ: XNCR) had its price target lowered by analysts at Wedbush from $31.00 to $26.00. They now have an "outperform" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor, Inc. (NASDAQ: XNCR) had its price target lowered by analysts at Wells Fargo & Company from $33.00 to $27.00. They now have an "overweight" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor (NASDAQ:XNCR) had its price target lowered by analysts at Royal Bank Of Canada from $32.00 to $15.00. They now have an "outperform" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor (NASDAQ:XNCR) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $26.00 price target on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor (NASDAQ:XNCR) had its "underweight" rating reaffirmed by analysts at Barclays PLC. They now have a $6.00 price target on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor (NASDAQ:XNCR) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $40.00 price target on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor (NASDAQ:XNCR) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
Ratings data for XNCR provided by MarketBeat
Xencor (NASDAQ:XNCR) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Ratings data for XNCR provided by MarketBeat
Xencor (NASDAQ:XNCR) had its price target raised by analysts at Cantor Fitzgerald from $40.00 to $42.00. They now have an "overweight" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor (NASDAQ:XNCR) had its price target raised by analysts at Royal Bank Of Canada from $18.00 to $19.00. They now have an "outperform" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor (NASDAQ:XNCR) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $26.00 price target on the stock.
Ratings data for XNCR provided by MarketBeat
Neueste Beiträge
Citigroup_Inc_ in Northrop Grumman Corp. diskutieren